Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Phase I/II Study of the Activin Receptor-Like Kinase 2 (ALK2) Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia Due to Myelofibrosis

Prithviraj Bose,Sanjay Mohan,Stephen Oh,Jason Gotlib,Ellen Ritchie,Taizo Shimomura,Haris Ali,Francoise Boyer,Paola Guglielmelli,Anthony Hunter,Betty Lamothe,Yi Cui,Francis Seguy,Amanda McBride, Francesca Palandri,Masahiro Takeuchi, Jean-Jacques Kiladjian

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

Cited 0|Views21
No score
Key words
MPN,myelofibrosis,Janus kinase,anemia,hepcidin,Phase I
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined